| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |